Evaluating the Feasibility of Disseminating a Novel Mobile Platform to Treat Depression (PRIME-D)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02817672|
Recruitment Status : Not yet recruiting
First Posted : June 29, 2016
Last Update Posted : June 29, 2016
|Condition or disease||Intervention/treatment|
|Depression||Behavioral: PRIME 1.0 Behavioral: PRIME 2.0|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Scaling a Smarter and More Efficient Intervention: Evaluating the Feasibility of Disseminating a Novel Mobile App Platform to Treat Depression|
|Study Start Date :||July 2017|
|Estimated Primary Completion Date :||June 2018|
Active Comparator: PRIME 1.0
8 weeks use of PRIME 1.0 (current version). Mobile application designed to improve psychosocial functioning and motivational deficits.
Behavioral: PRIME 1.0
Mobile application designed to improve psychosocial functioning and motivational deficits (sans NLP-powered dashboard).
Experimental: PRIME 2.0
8 weeks use of PRIME 2.0 (version with the NLP-powered dashboard). Mobile application designed to improve psychosocial functioning and motivational deficits.
Behavioral: PRIME 2.0
Mobile application designed to improve psychosocial functioning and motivational deficits (with NLP-powered dashboard).
- Depression severity [ Time Frame: Change from baseline to 3 month follow-up ]PhQ-9
- Functioning [ Time Frame: Change from baseline to 3 month follow-up ]Sheehan Disability Scale
- Coaching efficiency [ Time Frame: 8 weeks ]Flurry analytics
- Coaching competence [ Time Frame: 8 weeks ]Fidelity and competence assessment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02817672
|United States, California|
|University of California San Francisco|
|San Francisco, California, United States, 94143|
|Principal Investigator:||Danielle Schlosser, PhD||University of California, San Francisco|